New Rhode Island lab to develop vaccines

Researchers at the newly formed Institute for Immunology and Informatics at the University of Rhode Island will focus on developing vaccines for diseases that are rampant in poor countries, including malaria, dengue fever, AIDS and tuberculosis, using a "genome-to-vaccine" approach. The institute will have access to the bioinformatics tools of biotech firm EpiVax in exchange for partial rights to potential disease-prevention discoveries.

View Full Article in:

Providence Journal (R.I.) (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT